Compile Data Set for Download or QSAR

Found 3 hits of ic50 for monomerid = 47163   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Glycogen synthase kinase-3 beta (Homo sapiens (Human))	BDBM47163 (US8957103, A) Show SMILES COc1cc(cc(OC)c1OC)C1=C(C(=O)NC1=O)c1cn(CCCNC(=O)C(N)CC(C)C)c2ccccc12 |t:13| Show InChI InChI=1S/C30H36N4O6/c1-17(2)13-21(31)28(35)32-11-8-12-34-16-20(19-9-6-7-10-22(19)34)26-25(29(36)33-30(26)37)18-14-23(38-3)27(40-5)24(15-18)39-4/h6-7,9-10,14-17,21H,8,11-13,31H2,1-5H3,(H,32,35)(H,33,36,37)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	208	n/a	n/a	n/a	n/a	n/a	n/a
Johannes Gutenberg—Universitat Mainz US Patent					Assay Description The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...				US Patent US8957103 (2015) BindingDB Entry DOI: 10.7270/Q2SJ1J99
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM47163 (US8957103, A) Show SMILES COc1cc(cc(OC)c1OC)C1=C(C(=O)NC1=O)c1cn(CCCNC(=O)C(N)CC(C)C)c2ccccc12 |t:13| Show InChI InChI=1S/C30H36N4O6/c1-17(2)13-21(31)28(35)32-11-8-12-34-16-20(19-9-6-7-10-22(19)34)26-25(29(36)33-30(26)37)18-14-23(38-3)27(40-5)24(15-18)39-4/h6-7,9-10,14-17,21H,8,11-13,31H2,1-5H3,(H,32,35)(H,33,36,37)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Johannes Gutenberg—Universitat Mainz US Patent					Assay Description The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...				US Patent US8957103 (2015) BindingDB Entry DOI: 10.7270/Q2SJ1J99
					More data for this Ligand-Target Pair
Receptor-type tyrosine-protein kinase FLT3 (Homo sapiens (Human))	BDBM47163 (US8957103, A) Show SMILES COc1cc(cc(OC)c1OC)C1=C(C(=O)NC1=O)c1cn(CCCNC(=O)C(N)CC(C)C)c2ccccc12 |t:13| Show InChI InChI=1S/C30H36N4O6/c1-17(2)13-21(31)28(35)32-11-8-12-34-16-20(19-9-6-7-10-22(19)34)26-25(29(36)33-30(26)37)18-14-23(38-3)27(40-5)24(15-18)39-4/h6-7,9-10,14-17,21H,8,11-13,31H2,1-5H3,(H,32,35)(H,33,36,37)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Johannes Gutenberg—Universitat Mainz US Patent					Assay Description The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...				US Patent US8957103 (2015) BindingDB Entry DOI: 10.7270/Q2SJ1J99
					More data for this Ligand-Target Pair